Resources

BC Recommendations

Recommendations have been developed through the consensus of the Transfusion Medicine Advisory Group (TMAG), which consists of transfusion medicine physicians, technologists and nurses from hospitals across BC. The BC Provincial Blood Coordinating Office, Technical Resource Group and Nursing Resource Group have provided invaluable support for these initiatives.

Additionally the National Advisory Committee on Blood and Blood Products (NAC) has developed and endorsed a number of guidelines and recommendations.

Recommendations	BC Developed	NAC Developed	NAC Endorsed
Blood Components
Recommendations for Red Blood Cell Selection for Transfusion in Sickle Cell Disease - Section 9.6 (Oct 2023)	✓
AABB: Red Blood Cell Transfusion: 2023 AABB International Guidelines (Oct 2023)			✓
NAC: Recommendations for Use of Irradiated Blood Components (Apr 2023)		✓
NAC: Utilization and Inventory Management of Group O RH(D)- Negative Red Cells (Feb 2022)		✓
NAC: Appropriateness of use of CMV Seronegative vs. CMV Safe Product (Feb 2017)		✓
Plasma Protein and Related Products (PPRP)
Immune Globulin
Guidelines for SCIG Home Infusion Programs (Jan 2023)	✓
IVIG Utilization Management Program Recommendations (July 2019)	✓
PBCO IVIg Rheumatology Panel	✓
Guide for Treatment of Neurology Conditions with IVIg (Feb 2024)	✓
Neurology - PNS Conditions (Jan 2013)	✓
Neurology - CNS Conditions (Dec 2022)	✓
PID Diagnostic and Treatment Recommendations (May 2018)	✓
SID Recommendations (Jan 2024)	✓
Other PPRPs
ICTMG: Intravenous Albumin (Aug 2024)			✓
Transfusion Medicine Processes
Cross-Health Authority Transfusion Reaction Recommendation (Mar 2024)	✓
NAC: Recommendations for the Notification of Recipients of a Blood Component Recall (July 2023)		✓

Recommendations have been developed through the consensus of the Transfusion Medicine Advisory Group (TMAG), which consists of transfusion medicine physicians, technologists and nurses from hospitals across BC. The BC Provincial Blood Coordinating Office, Technical Resource Group and Nursing Resource Group have provided invaluable support for these initiatives. Recognizing the evolution of formalized processes for the development of "guidelines," the latter term was replaced by the term "recommendations" in 2014. Historical document titles are unchanged.

Below is a list of recommendations either developed or endorsed by BC transfusion stakeholders.

BC Recommendations	Dated
Cross-Health Authority Transfusion Reaction Recommendation	Mar 2024
Guidelines for SCIG Home Infusion Programs	Jan 2023
IVIG Utilization Management Program Recommendations	July 2019
TMAG Recommendations for O Neg Use in Emergency Transfusions	Aug 2018
Hereditary Angioedema Treatment Recommendations	Jan 2016
Recommendations for RBC Transfusion	Jun 2014
Guidelines for Albumin Use for Adults in BC	Oct 2007
Guidelines for the Use of CMV Seronegative Blood Products Note: this section is under review to align with the most recent NAC Recommendations endorsed by TMAG	Apr 2007
Guidelines for Implementation of Informed Consent for Blood and Blood Products	Apr 1999
BC Endorsed Recommendations	Dated
NAC: Recommendations for the Notification of Recipients of a Blood Component Recall	July 2023
TM Medical Policy Manual - Recommendations	Dated
Irradiation of Blood Components - Section 6.2 of the TM Medical Policy Manual Note: this section is under review to align with the most recent NAC Recommendations endorsed by TMAG	Mar 2015
Technical Recommendations for the Appropriate Use of Blood Components in Neonates and Infants Less Than 4 Months of Age - Section 8.1 of the TM Medical Policy Manual	Jun 2015
Clinical Recommendations for the Appropriate Use of Blood Components in Neonates and Infants Less Than 4 Months of Age - Section 8.2 of the TM Medical Policy Manual	Jun 2015
Sickle Cell Recommendations - Section 9.6 of the TM Medical Policy Manual	Oct 2023

Link

BC Recommendations

Recommendations (DRAFT)

BC Recommendations

I need to...

I need to go to...